| ZELINKA, Jiří, Jiří BLAHÁK, Vojtěch PEŘINA, Rita PACASOVÁ, Jana TREGLEROVÁ a Oliver BULIK. The use of platelet-rich fibrin in the surgical treatment of medication-related osteonecrosis of the jaw: 40 patients prospective study. Biomedical Papers. Univerzita Palackého v Olomouci, 2021, roč. 165, č. 3, s. 322-327. ISSN 1213-8118. Dostupné z: https://dx.doi.org/10.5507/bp.2020.023. |
Další formáty:
BibTeX
LaTeX
RIS
@article{1771658,
author = {Zelinka, Jiří and Blahák, Jiří and Peřina, Vojtěch and Pacasová, Rita and Treglerová, Jana and Bulik, Oliver},
article_number = {3},
doi = {http://dx.doi.org/10.5507/bp.2020.023},
keywords = {medication related osteonecrosis of the jawplatelet rich fibrinsurgical treatment},
language = {eng},
issn = {1213-8118},
journal = {Biomedical Papers},
note = {Bez afiliace k MU.},
title = {The use of platelet-rich fibrin in the surgical treatment of medication-related osteonecrosis of the jaw: 40 patients prospective study},
url = {https://biomed.papers.upol.cz/artkey/bio-202103-0013_the-use-of-platelet-rich-fibrin-in-the-surgical-treatment-of-medication-related-osteonecrosis-of-the-jaw-40-pa.php?back=%2Fsearch.php%3Fquery%3DZelinka%2Bin%253Aauth%2Bname%2Bkey%2Babstr%26sfrom%3D0%26},
volume = {165},
year = {2021}
}
TY - JOUR
ID - 1771658
AU - Zelinka, Jiří - Blahák, Jiří - Peřina, Vojtěch - Pacasová, Rita - Treglerová, Jana - Bulik, Oliver
PY - 2021
TI - The use of platelet-rich fibrin in the surgical treatment of medication-related osteonecrosis of the jaw: 40 patients prospective study
JF - Biomedical Papers
VL - 165
IS - 3
SP - 322-327
EP - 322-327
PB - Univerzita Palackého v Olomouci
SN - 12138118
N1 - Bez afiliace k MU.
KW - medication related osteonecrosis of the jawplatelet rich fibrinsurgical treatment
UR - https://biomed.papers.upol.cz/artkey/bio-202103-0013_the-use-of-platelet-rich-fibrin-in-the-surgical-treatment-of-medication-related-osteonecrosis-of-the-jaw-40-pa.php?back=%2Fsearch.php%3Fquery%3DZelinka%2Bin%253Aauth%2Bname%2Bkey%2Babstr%26sfrom%3D0%26
N2 - Medication-related osteonecrosis of the jaw (MRONJ) is defined as exposed bone in the maxillofacial region persisting for more than eight weeks in patients who are or were treated with antiresorptive or antiangiogenic agents and had no radiation therapy to the craniofacial region or obvious metastatic disease of the jaws. It is a recognised side effect of antiresorptive or antiangiogenic medication. To date, there is no specific gold standard treatment for MRONJ cases. The aim of this study was to evaluate the successful rate of surgical treatment with adjuvant local application of platelet rich fibrin.
ER -
ZELINKA, Jiří, Jiří BLAHÁK, Vojtěch PEŘINA, Rita PACASOVÁ, Jana TREGLEROVÁ a Oliver BULIK. The use of platelet-rich fibrin in the surgical treatment of medication-related osteonecrosis of the jaw: 40 patients prospective study. \textit{Biomedical Papers}. Univerzita Palackého v Olomouci, 2021, roč.~165, č.~3, s.~322-327. ISSN~1213-8118. Dostupné z: https://dx.doi.org/10.5507/bp.2020.023.
|
